Myeloablative TBI is associated with increased risk of pulmonary GVHD in patients undergoing allogeneic hematopoietic stem cell transplant

Affiliations

• ¹ Division of Hematology, Oncology and Cellular Therapy, Department of Medicine, Rush University Medical Center, Chicago, IL, USA.
• ² Division of Hematology and Medical Oncology, Department of Medicine, John H. Stroger, Jr. Hospital of Cook County, Chicago, IL, USA.
• ³ Rush Bioinformatics and Biostatistics Core, Rush University, Chicago, IL, USA.
• ⁴ Department of Pharmacy, Rush University Medical Center, Chicago, IL, USA.
• ⁵ Department of Radiation Oncology, Rush University Medical Center, Chicago, IL, USA.
• ⁶ Division of Cardiology-Oncology, Department of Medicine, Rush University Medical Center, Chicago, IL, USA.
• ⁷ Division of Hematology, Oncology and Cellular Therapy, Department of Medicine, Rush University Medical Center, Chicago, IL, USA. celalettin_ustun@rush.edu.